Baby Breaker Birth Announcements

Welcome back to Baby Breakerdom! This week's quest to find budding Rule Breakers reveals another biotech upstart pulling away from the stock market and a Baby Breaker that wants you to shop till you drop.

We start with Intarcia Therapeutics, which a week ago cited unfavorable market conditions in pulling its planned IPO, which could have raised more than $86 million. That's just spooky. Earlier in the year, EpiCept did the same thing and then three weeks ago spent $136 million worth of stock to buy Maxim Pharmaceuticals (Nasdaq: MAXM  ) instead.

That Intarcia blinked may be bad news for investors hoping to cash in soon on Intarcia's breast cancer treatment, but it could prove smart in the long run. I mean, really, with competitors like Genentech (NYSE: DNA  ) and Rule Breaker Universe member Dendreon (Nasdaq: DNDN  ) , Intarcia can't afford to make a financing error. Besides, it's not as though Intarcia is desperate for moola right now. VentureWire reports that the company had more than $46 million in cash and equivalents as of June 30. That ought to be more than enough to fund operations through phase 3 trials, which are ongoing.

Moving on to the malls of cyberspace, comparison shopper received $25 million in new venture funding from a group led by Oak Investment Partners. The hope, it appears, is to capture some of the love that's been bestowed on its rivals in recent months. For example, in June, eBay (Nasdaq: EBAY  ) paid $620 million for Then, a week later, another "e" arrived on the scene. This time it was E.W. Scripps (NYSE: SSP  ) , which snapped up Shopzilla for $525 million. has to like its chances for a very healthy liquidating event, given that history. But it isn't sitting idle. VentureWire reports that the additional cash will fund marketing and customer service initiatives aimed at boosting traffic. Other priorities probably include the company's shopping platform, which operates in multiple languages and currencies and combines data from different merchants into a single, customizable Web page. Hmmmm. ... That's exactly the kind of Rule Breaking innovation my wife would really appreciate. You won't tell her, will you?

Finally, in Baby Breaker public offerings, Caribou Coffee (Nasdaq: CBOU  ) debuted Thursday with a whimper. After opening at $15.50 -- well above its IPO price of $14 a share -- the stock of the wannabe Starbucks (Nasdaq: SBUX  ) declined sharply to close at $13. It's down an additional 11% in Friday's midday trading. Ouch. Don't you need rope and a harness for that kind of descent?

That's it for this week. See you back here next Friday, when we continue the quest for the next ultimate growth stock.

For more Rule Breaking Foolishness:

  • Who are the giant killers and what can they do for your portfolio?
  • You can find out which are the four stocks to buy in 2006.
  • Sometimes insiders buy for all the right reasons. Who was at it this week?

Netflix.Marvel. AOL. Starbucks. Find out how David Gardner landed these and other multibaggers by taking a risk-free trial to Motley Fool Rule Breakers today. Your portfolio will thank you.

eBay is a Motley Fool Stock Advisor recommendation.

Fool contributor Tim Beyers has been to Starbucks so many times this week, he's actually beginning to miss his basement office. Tim didn't own stock in any of the companies mentioned in this story at the time of publication. You can find out what is in his portfolio by checking Tim's Fool profile, which is here. The Motley Fool has an ironclad disclosure policy.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 496688, ~/Articles/ArticleHandler.aspx, 10/26/2016 3:53:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 6 hours ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
CBOU.DL $0.00 Down +0.00 +0.00%
Caribou Coffee Com… CAPS Rating: ***
DNA $94.97 Down +0.00 +0.00%
Genentech CAPS Rating: ****
DNDNQ $0.00 Down +0.00 +0.00%
Dendreon Corp CAPS Rating: *
EBAY $29.05 Down -0.17 -0.58%
eBay CAPS Rating: ****
SBUX $53.67 Down -0.51 -0.94%
Starbucks CAPS Rating: ****
SSP $13.65 Down -0.30 -2.15%
The E.W. Scripps C… CAPS Rating: *